RECENT COMMENTS

Rajesh Kumar: Is it helpfull for Overian cancer patient at advance stage? Rajesh Kumar +919681303310   »Read more

Cindy: I'm not a medical professional. My mother has been diagnosed with CUP - and was treated several year [...]   »Read more

Rajesh Kumar: +919681303310.   »Read more

Rajesh Kumar: Please write your comment here   »Read more

christian: Is gabapentin has been proposed to treat peripheric neuropathy induced by chemotherapy. At low dosa [...]   »Read more

Cover Story

Issue 44
Julio Celis:  bridging science and politics
Issue 43
Peter Naredi:  a 'can do' leader for Europe's cancer surgeons
Issue 42
Jean-Yves Blay:  integrating translational and clinical research
Issue 41
Ruth Ladenstein: raising standards of care for our young patients
Issue 40
Klaus Meier: together we can offer the best of both worlds
Issue 39
Sara Faithfull: unleashing the potential of cancer nursing
Issue 38
Angelo di Leo: mapping the geography of breast cancer
Issue 37
Serigne Magueye Gueye: an agent for change
Issue 36
Jaap Verweij: an intelligent approach to drugs
Issue 35
Alain Fourquet: taking multidisciplinarity one step further
Issue 34
Jan Geissler: We, the patients
Issue 33 
Vesna Kesic: exporting excellence in women's cancers
Issue 32
Eric Van Cutsem: closing in on GI tumours
Issue 31
Michael Gnant: pushing the boundaries
Issue 30
Pat Price: asking the right questions
Issue 29 
Emiel Rutgers: a surgeon for the genomic era
Issue 28
Jean-Pierre Droz: We can do better for our older patients 
Issue 27 
Paolo Casali: the man with the method 
Issue 26 
Nadia Harbeck: breaking with convention 
Issue 25
Mike Richards: the man with the plan 
Issue 24 
Ulrik Ringborg: tackling the fragmentation of Europe's cancer efforts 
Issue 23
Giovanni Paganelli: nuclear medicine's enthusiastic ambassador 
Issue 22
Clifton Leaf: asking the difficult questions 
Issue 21
Hein Van Poppel: urological cancer is what we do 
Issue 20
Michael Stevens: curing the whole child 
Issue 19
Nicholas Pavlidis: on the path of Hippocrates 
Issue 18
Tanja Cufer: all the confidence of new Europe 
Issue 17
Aron Goldhirsch: dogmatically anti-dogma 
Issue 16
Jan Foubert: champion of cancer nursing 
Issue 15
Lynn Faulds Wood: tell it like it is 
Issue 14
Jacques Bernier: Keeping the faith 
Issue 13
David Khayat: driving the French cancer plan 
Issue 12
Laura van't Veer: the person behind personalised treatments 
Issue 11
Lesley Fallowfield: getting the message across 
Issue 10
Michael Baumann: the dynamo of Dresden 
Issue 9
Fatima Cardoso: the next generation 
Issue 8
John Smyth: unity is strength 
Issue 7 
Peter Boyle: the man behind the statistics 
Issue 6
José Baselga: playing to Europe's strengths 
Issue 5
Bruce Ponder: plugging the research 
Issue 4
Stella Kyriakides: the torch bearer 
Issue 3
Lars Påhlman: Super-Specialist 
Issue 2
Lex Eggermont: a rare hybrid 
Issue 1
Cora Sternberg: An American in Rome 

 
 

e-ESO.net

E-eso

Online educational resources Including e-grandrounds, weekly online meetings in collaboration with Nature Reviews Clinical Oncology - CME accredited!

Next live sessions:

GR16 - Cardiac side effects of molecular targeted therapies: Towards a better dialogue between oncologists and cardiologists (based on a review article of Critical Reviews in Oncology Hematology)

GR182 - Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers

GR183 - The current management of low-grade glioma in childhood

The website is supported by an unrestricted educational grant provided by:

Founding sponsor

CancerWorld invites you to visit:

E-eso
European School of Oncology -
ESO Established in 1982, a non-profit organisation exclusively dedicated to increasing the knowledge of health professionals in cancer care.
E-aso
Euro-Arab School of Oncology - is a joint initiative between the Egyptian Ministry of Health and Population and ESO. EASO intends to enhance and support education in the oncology field in all the Arab countries.
 
ECPC
ECPC
Europa Donna
Europa
Donna
Europa Uomo
Europa
Uomo
EONS
EONS
SIOG
SIOG
The challenge Fund
The
Challenge
Fund
Seno network
SenoNetwork
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, Celgene, Eisai, Eli Lilly, Genomic Health, GlaxoSmithKline, Merck Serono, Novartis, Roche and Sanofi Aventis.